[α]D25 Ϫ27.9 (c 6.05 in CH3OH)}; νmax(neat) 3034, 2972, 2879,
1705, 1654, 1541, 1498, 1449; m/z (EI) 245 (Mϩ, 0.2%), 204 (2),
186 (1), 160 (9), 154 (3), 139 (7), 114 (18), 91 (100) (Found: C,
73.03; H, 8.07; N, 6.16. Calc. for C15H19NO2: C, 73.43; H, 7.80;
N, 5.71%).
The reaction mixture was stirred under H2 (1 atm) for 10 h, then
filtered through Celite and concentrated in vacuo to give a
slightly yellow crude product, which was recrystallised to pro-
vide 9 (19 mg, 80%) as colorless needles, mp 88.3–91.1 ЊC (from
n-hexane–diethyl ether) {lit.,9 89–91 ЊC; lit.,7 90–92 ЊC; lit.,10
94–95 ЊC}; [α]D26–50.7 (c 0.55 in CHCl3) {lit.,7 [α]D21 Ϫ47.0 (c 0.97
in CHCl3); lit.,9 [α]2D9 Ϫ53.0 (c 0.97 in CHCl3); lit.,10 [α]D22 Ϫ55.0
(c 0.79 in CHCl3)}; νmax(KBr) 3370, 2971, 2881, 1616, 1475,
1412; m/z (EI) 170 (Mϩ ϩ 1, 26%), 169 (Mϩ, 41), 154
(Mϩ Ϫ CH3, 4), 126 (16), 112 (15), 111 (18), 99 (13), 98 (12), 83
(81), 70 (100); δH (400 MHz; CDCl3) 3.45 (dd, J 4.4 and 9.5,
2H), 3.30 (dd, J 5.6 and 10, 1H), 3.15 (s, 1H, disappeared when
exchanged with D2O), 2.50 (ddd, J 7.2, 11.2 and 18.6, 1H), 2.35
(dd, J 7.2 and 18.2, 1H), 1.65–2.00 (m, 6H), 1.20 (s, 3H).
For 10, mp 128.3–129.7 ЊC (from n-hexane–diethyl ether); [α]D25
Ϫ57.8 (c 0.6 in CHCl3); νmax(KBr) 3279, 2952, 2885, 1610, 1483,
1450, 1413; m/z (EI) 170 (Mϩ ϩ 1, 11.5%), 169 (Mϩ, 32), 154
(Mϩ Ϫ CH3, 4), 136 (1), 112 (13), 111 (16), 99 (12), 98 (11), 83
(79), 70 (100); δH (300 MHz; CDCl3) 3.50 (m, 3H), 2.50 (ddd,
J 3.8, 6.0 and 17.5, 1H), 2.35 (dd, J 7.3 and 18.0, 1H), 2.30 (s,
1H), 1.60–2.15 (m, 6H), 1.20 (s, 3H).
(2S)-2-Acetyl-N-(benzyloxycarbonyl)pyrrolidine 7
To a solution of 6 (389 mg, 1.58 mmol) in absolute MeOH (100
ml) at Ϫ78 ЊC was introduced O3 until the reaction became blue
(ca. 10 min), followed by introduction of O2 to make the solu-
tion colorless again and then the reaction mixture was allowed
to warm to room temperature. To the solution was added Me2S
(0.5 ml) and the mixture was stirred for 30 min. Concentration
and purification by chromatography (PS–EA 3:1) gave 7 (351
mg, 90%) as a colorless oil, [α]D20 Ϫ43.9 (c 2.1 in CHCl3) {lit.,9 [α]D27
Ϫ42.2 (c 1.0 in CHCl3)}; νmax(neat) 3034, 2958, 2884, 1704,
1499, 1448, 1416; m/z (EI) 248 (Mϩ ϩ 1, 0.15%), 204 (13), 160
(18), 91 (100) (Found: C, 67.60; H, 7.12; N, 5.60. Calc. for
C14H17NO3: C, 68.00; H, 6.93; N, 5.66%).
Ethyl 4-[(2ЈS)-N-(benzyloxycarbonyl)pyrrolidin-2Ј-yl]-4-hydroxy-
pent-2-ynoate 8
Acknowledgements
To a solution of Pri2NH (0.16 ml, 1.09 mmol) in THF (6 ml)
was added dropwise 1.6 M n-BuLi (0.68 ml, 1.09 mmol) at 0 ЊC.
The solution was then warmed to room temperature and stirred
for 20 min. After it had been cooled to Ϫ78 ЊC and ethyl propi-
olate (0.12 ml, 1.09 mmol) had been added dropwise, the reac-
tion mixture was stirred for 70 min. Then TiCp2Cl2 (14 mg,
0.055 mmol) was added and the mixture was stirred for another
20 min. A solution of 7 (135 mg, 0.546 mmol) in THF (1 ml)
was added dropwise. Stirring at Ϫ78 ЊC was continued until the
starting material had disappeared on TLC. The reaction mix-
ture was treated dropwise with saturated aq. NH4Cl, extracted
with diethyl ether, and the extract was washed (brine) and dried
(Na2SO4). Concentration, and purification by chromatography
(PS–EA 4:1) gave 8a and 8b (150 mg, 80%) in the ratio 7.5:1 as
a yellow liquid: 8a [α]D24 ϩ217.4 (c 1.3 in CHCl3); νmax(neat) 3331,
3035, 2985, 2899, 2243, 1712, 1670, 1499, 1455, 1413; m/z (EI)
346 (Mϩ ϩ 1, 0.4%), 328 (0.8), 302 (1), 204 (13), 160 (39), 91
(100); δH (300 MHz; CDCl3) 7.40 (m, 5H), 6.00 (br s, 1H), 5.15
(s, 2H), 4.30 (m, 1H), 4.23 (q, J 7.1, 2H), 3.71–3.79 (m, 1H),
3.36–3.44 (m, 1H), 1.67–2.26 (m, 4H), 1.41 (s, 3H), 1.30 (t, J 7.1,
3H) (Found: C, 66.22; H, 6.64; N, 4.13. Calc. for C19H23NO5: C,
66.06; H, 6.71; N, 4.06%).
We thank the Analytical Department of the Shanghai Institute
of Organic Chemistry, Academia Sinica for help with elemental
analysis and HPLC assay.
References
1 (a) J. W. Daly, H. M. Garraffo and T. F. Spande, The Alkaloids,
ed. G. A. Cordell, Academic Press, San Diego, 1993, vol. 43, p. 185;
(b) J. W. Dale and T. F. Spande, in Alkaloids: Chemical and
Biological Perspectives, ed. S. W. Pelletier, John Wiley & Sons, New
York, 1986, vol. 4, p. 1; (c) T. Tokuyama, N. Nishimori, A. Shimada,
M. W. Edwards and J. W. Daly, Tetrahedron, 1987, 43, 643; (d) H. M.
Garraffo, M. W. Edwards, T. F. Spande, J. W. Daly, L. E. Overman,
C. Severini and V. Erspamer, Tetrahedron, 1988, 44, 6795; (e) L. E.
Overman and A. S. Franklin, Chem. Rev., 1996, 96, 505.
2 (a) J. W. Daly, C. W. Myers and N. Whittaker, Toxin, 1987, 25, 1023;
(b) J. W. Daly, F. Gusovsky, E. T. McNeal, S. Secunda, M. Bell,
C. R. Creveling, Y. Nichirawa, L. E. Overman, M. J. Sharp and
D. P. Rossignol, Biochem. Pharmacol., 1990, 40, 315; (c) ref. 1
(a) and (b).
3 (a) J. W. Daly and C. W. Myers, Science, 1967, 156, 970; (b) J. W.
Daly, T. Tokuyama, G. Habermehl, I. L. Karle and B. Witkop,
Justus Liebigs Ann. Chem., 1969, 729, 198.
4 J. W. Daly, T. Tokuyama, T. Fujiwara, R. J. Highet and I. L. Karlet,
J. Am. Chem. Soc., 1980, 102, 830.
5 (a) L. E. Overman and K. L. Bell, J. Am. Chem. Soc., 1981, 103,
1851; (b) L. E. Overman, K. L. Bell and F. Ito, J. Am. Chem. Soc.,
1984, 106, 4192.
6 B. M. Trost and T. S. Scanlan, J. Am. Chem. Soc., 1989, 111, 4988.
7 D. N. A. Fox, D. Lathbury, M. F. Mahon, K. C. Molloy and
T. Gallagher, J. Am. Chem. Soc., 1991, 113, 2652.
For 8b [α]D24 Ϫ108.8 (c 3.24 in CHCl3); νmax(neat) 3286, 2985,
2241, 1712, 1668, 1499, 1454, 1419; m/z (EI) 346 (Mϩ ϩ 1,
0.3%), 328 (0.5), 302 (0.4), 204 (13), 160 (39), 91 (100); δH (300
MHz; CDCl3;) 7.30 (m, 5H), 5.14 (s, 2H), 4.17 (q, J 7.1, 2H),
3.94 (t, J 7.5, 1H), 3.75 (dt, J 3.1 and 7.6, 1H), 3.35 (m, 1H),
1.64–2.15 (m, 4H), 1.42 (s, 3H), 1.24 (t, J 7.1, 3H) (Found: C,
65.94; H, 6.78; N, 4.33. Calc. for C19H23NO5: C, 66.06; H, 6.71;
N, 4.06%).
8 I. Cossy, M. Cases and D. G. Pardo, Synlett, 1996, 909.
9 A. G. Barrett and F. Damiani, J. Org. Chem., 1999, 64, 1410.
10 S. F. Martin and S. K. Bur, Tetrahedron, 1999, 55, 8905.
11 P. Garner and J. M. Park, J. Org. Chem., 1990, 55, 3772.
12 M. Chen and J. Fang, J. Org. Chem., 1992, 57, 2937.
13 A. Ito, R. Takahashi and Y. Baba, Chem. Pharm. Bull., 1975, 23,
3081.
(8S,8aS)-8-Hydroxy-8-methylindolizidin-5-one 9 and (8R,8aS)-
8-hydroxy-8-methylindolizidin-5-one 10
To a solution of 8a (or 8b for compound 10) (49 mg, 0.142
mmol) in absolute MeOH (3 ml) was added 5% Pd/C (15 mg).
14 K. Soai, H. Machida and N. Yokota, J. Chem. Soc., Perkin Trans. 1,
1987, 1909.
3266
J. Chem. Soc., Perkin Trans. 1, 2000, 3264–3266